Contact Lenses for Everyone, Everyday.
We’re a global leader in contact lenses. With the widest range of prescription options,*1 trust in CooperVision for a contact lens that meets your vision, lifestyle and budget needs.
Find an eye doctor today
Our locator tool makes it easy to find an eye doctor or practice near you.
Try a free pair of contact lenses
Talk to your doctor to experience the comfort and clear vision for yourself.
Claiming a rebate is easy
You may be eligible for rebate savings on CooperVision products. Learn More.
Unsure about which lenses are right for you?
Take this four question quiz to discover which of our products may best fit your needs, then talk to your eye care practitioner for more information and guidance.
Takes 1 minute
Myopia Blog
Can My Child’s Nearsightedness Be Cured?
Why is Vision Blurry After Looking at a Screen for Too Long?
How Do MiSight® 1 Day Contact Lenses Work?
Styes: How We Get Them and How to Get Rid of Them
Claiming a rebate is easy
You may be eligible for rebate savings on CooperVision products.
About CooperVision
CooperVision is one of the world’s leading contact lens companies, serving eye care professionals and lens wearers in over 130 countries.†1 Our innovative products help millions of people see better each day.
*Based on Rx option combinations (sphere, cylinder, axis & add) manufactured, across all soft lenses in sphere, toric & multifocal, in SiHy and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included.
†CooperVision® soft and specialty contact lenses and spectacle lenses.
References:
1. CVI data on file, 2024. Based on Tyler's Quarterly and competitor websites, 9/2024.
2. CVI data on file, 2024.
3. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.
4. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8)556-567.
5. Chamberlain P et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. BCLA paper presentation 2019.
6. CVI data on file, 2018. clariti 1 day satisfaction survey, n=1718. CVI data on file, 2018. 1-week bilateral DW study with c1d toric, n=39. CVI data on file, 2019. Woods J et al. Visual performance with DD SiH CN progressive design MFCL.
7. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study with MyDay® multifocal; n=102 habitual MFCL wearers.
8. CVI data on file, 2023.
18892 11/25